From libraries to candidate: The discovery of new ultra long-acting dibasic β2-adrenoceptor agonists-Reference-Cited by-同舟云学术

From libraries to candidate: The discovery of new ultra long-acting dibasic β2-adrenoceptor agonists

Published:2012-01 Issue:1 Volume:22 Page:689-695
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Alcaraz Lilian,Bailey Andrew,Cadogan Elaine,Connolly Stephen,Jewell Robert,Jordan Stephen,Kindon Nicholas,Lister Andrew,Lawson Mandy,Mullen Alexander,Dainty Ian,Nicholls David,Paine Stuart,Pairaudeau Garry,Stocks Michael J.,Thorne Phillip,Young Alan

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference40 articles.

1. β-Adrenoceptor agonists and asthma—100 years of development

2. Optimal assessment and management of chronic obstructive pulmonary disease (COPD)

3. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

4. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

5. Clinical Management of Chronic Obstructive Pulmonary Disease;MacNee,2007

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, Synthesis, and Evaluation of Lung-Retentive Prodrugs for Extending the Lung Tissue Retention of Inhaled Drugs;Journal of Medicinal Chemistry;2022-07-07

2. Simplified, interpretable graph convolutional neural networks for small molecule activity prediction;Journal of Computer-Aided Molecular Design;2021-11-24

3. Discovery of M3 Antagonist-PDE4 Inhibitor Dual Pharmacology Molecules for the Treatment of Chronic Obstructive Pulmonary Disease;Journal of Medicinal Chemistry;2021-06-18

4. The API;Inhaled Medicines;2021

5. Investigational beta-2 adrenergic agonists for the treatment of chronic obstructive pulmonary disease;Expert Opinion on Investigational Drugs;2017-02-06